The story of Sildenafil presents a interesting case for stakeholders in the pharmaceutical sector. While initially a tremendous success, producing billions, the patent expiration and the subsequent flood of off-brand https://porn695830.xzblogs.com/82120067/the-little-copyright-and-big-pharma-a-speculative-investment